Yousif Capital Management LLC Sells 650 Shares of Globe Life Inc. (NYSE:GL)

Yousif Capital Management LLC lowered its position in Globe Life Inc. (NYSE:GL) by 5.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 11,624 shares of the company’s stock after selling 650 shares during the period. Yousif Capital Management LLC’s holdings in Globe Life were worth $1,296,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of GL. Exchange Traded Concepts LLC bought a new stake in shares of Globe Life during the 3rd quarter valued at about $247,000. Creative Planning lifted its stake in Globe Life by 43.8% in the third quarter. Creative Planning now owns 32,477 shares of the company’s stock valued at $3,440,000 after buying an additional 9,892 shares during the period. nVerses Capital LLC boosted its holdings in shares of Globe Life by 1,150.0% during the 3rd quarter. nVerses Capital LLC now owns 2,500 shares of the company’s stock worth $265,000 after buying an additional 2,300 shares in the last quarter. Net Worth Advisory Group acquired a new stake in shares of Globe Life during the 3rd quarter worth approximately $674,000. Finally, Riverview Trust Co bought a new stake in shares of Globe Life in the 3rd quarter valued at $32,000. 81.61% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Globe Life news, CEO James Matthew Darden sold 24,890 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total value of $3,024,632.80. Following the sale, the chief executive officer now owns 38,973 shares of the company’s stock, valued at $4,735,998.96. This trade represents a 38.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now owns 5,122 shares of the company’s stock, valued at approximately $579,964.06. This trade represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 64,678 shares of company stock valued at $7,454,412. Corporate insiders own 1.51% of the company’s stock.

Globe Life Price Performance

Globe Life stock opened at $123.58 on Friday. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The business’s 50 day simple moving average is $114.32 and its 200 day simple moving average is $107.77. Globe Life Inc. has a 12 month low of $38.95 and a 12 month high of $132.00. The company has a market cap of $10.37 billion, a price-to-earnings ratio of 10.34 and a beta of 0.81.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. Sell-side analysts forecast that Globe Life Inc. will post 13.57 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Piper Sandler upped their price target on Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and upped their target price for the stock from $132.00 to $143.00 in a research report on Wednesday, January 8th. Morgan Stanley lifted their price target on shares of Globe Life from $123.00 to $125.00 and gave the company an “equal weight” rating in a research report on Tuesday. Jefferies Financial Group upped their price objective on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a report on Tuesday, December 10th. Finally, BMO Capital Markets began coverage on shares of Globe Life in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Globe Life has an average rating of “Moderate Buy” and an average price target of $133.10.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.